Over half of people diagnosed with advanced melanoma are now surviving the disease for ten years or more when they receive a ...

Postdoctoral researchers – also known as postdocs – are essential to scientific research. After completing their doctoral ...

A study has found that people with Li-Fraumeni syndrome would benefit from yearly whole-body MRI scans to screen for cancers ...

Image: The Breast Cancer Now Generations Study team at The Institute of Cancer Research, London. Scientists are developing ...

We are currently advertising one fully-funded PhD project and the application deadline is Sunday 1st September 2024. Below you will find a link to further information about our application process, ...

The Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

What is the study about? FAST-Forward is investigating whether a shorter course of radiotherapy treatment for people with breast cancer is as safe and effective as the standard longer course. When ...

The ICR-CTSU is a CR-UK funded, internationally recognised methodologist led clinical trials unit, providing cancer-focussed clinical trial research expertise. We lead pioneering, efficient, ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

Professor Chris Lord is Deputy Head of Division and the leader of the CRUK Gene Function Group, which applies concepts such as synthetic lethality and non-oncogene addiction to provide one route to ...

NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals. The ...